Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL) von Duvic, Madeleine, Talpur, Rakshandra, Ni, Xiao, Zhang, Chunlei, Hazarika, Parul, Kelly, Cecilia, Chiao, Judy H., Reilly, John F., Ricker, Justin L., Richon, Victoria M., Frankel, Stanley R.

Volltext

Clinical characteristics, risk factors and long-term outcome of 114 patients with folliculotropic mycosis fungoides von Wieser, Iris, Wang, Casey, Alberti-Violetti, Silvia, Lyons, Genevieve, Tran, Casey, Talpur, Rakshandra, Duvic, Madeleine

Volltext

Treatment of cutaneous T cell lymphoma: current status and future directions von Apisarnthanarax, Narin, Talpur, Rakshandra, Duvic, Madeleine

Volltext

Atypical Lymphoid Infiltration Occurring at the Site of a Healed Varicella Zoster Infection von Talpur, Rakhshandra, Duvic, Madeleine

Volltext